Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant Staphylococcus aureus (MRSA)

By sjmartinez • February 26, 2025

Li Y, Berti AD, Abdelhady W, Xiong YQ. Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics (Basel). 2025 Feb 13;14(2):191. doi: 10.3390/antibiotics14020191. PMID: 40001434.

Tags: Harbor UCLA, Infectious Diseases, MRSA endovascular infections, prophage, Publications, vancomycin persistence

COVID-19 Has Taught Us That Not All COPD Exacerbations are Created Equal

Stringer WW. COVID-19 Has Taught Us That Not All COPD Exacerbations are Created Equal. Ann Am Thorac Soc. 2026 Jun 8:aaoag153. doi: 10.1093/annalsats/aaoag153. Epub ahead[...]

Beyond Breathing: Lung as a Sensory Organ A Report from the NHLBI Workshop on Lung Sensing and its Implication in Diseases

Jendzjowsky N, Kuo CS, Reznikov LR, Chen Z, Li P, Prescott S, Liu Y, Seeholzer L, Tschumperlin DJ, Taylor-Clark TE, Rajagopal J, Haber AL, Noël[...]

Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide

Olson TE, Lloyd TS, Hamad CD, Chun RF, Wiener J, Golzar A, Mehany J, Shahamatdar S, Kittredge A, Pearce L, Francis KP, Obeidin F, Holly[...]